Shares of Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) traded down 1% on Thursday . The stock traded as low as $2.2738 and last traded at $2.3175. 3,650 shares traded hands during trading, a decline of 72% from the average session volume of 13,006 shares. The stock had previously closed at $2.34.
Medexus Pharmaceuticals Stock Performance
The business has a 50-day simple moving average of $2.10 and a two-hundred day simple moving average of $2.04.
About Medexus Pharmaceuticals
Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.
Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.
Read More
- Five stocks we like better than Medexus Pharmaceuticals
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
